These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 28651487)
21. High lymphatic vessel density and presence of lymphovascular invasion both predict poor prognosis in breast cancer. Zhang S; Zhang D; Gong M; Wen L; Liao C; Zou L BMC Cancer; 2017 May; 17(1):335. PubMed ID: 28514957 [TBL] [Abstract][Full Text] [Related]
22. Prognostic impact of vascular and lymphovascular invasion in early lung cancer. Al-Alao BS; Gately K; Nicholson S; McGovern E; Young VK; O'Byrne KJ Asian Cardiovasc Thorac Ann; 2014 Jan; 22(1):55-64. PubMed ID: 24585645 [TBL] [Abstract][Full Text] [Related]
23. Indicators of loco-regional recurrence in breast cancer. The South East Swedish Breast Cancer Group. Sundquist M; Thorstenson S; Klintenberg C; Brudin L; Nordenskjöld B Eur J Surg Oncol; 2000 Jun; 26(4):357-62. PubMed ID: 10873355 [TBL] [Abstract][Full Text] [Related]
24. Analysis in early stage triple-negative breast cancer treated with mastectomy without adjuvant radiotherapy: patterns of failure and prognostic factors. Chen X; Yu X; Chen J; Zhang Z; Tuan J; Shao Z; Guo X; Feng Y Cancer; 2013 Jul; 119(13):2366-74. PubMed ID: 23576181 [TBL] [Abstract][Full Text] [Related]
25. The clinical significance of downregulation of mir-124-3p, mir-146a-5p, mir-155-5p and mir-335-5p in gastric cancer tumorigenesis. Li H; Xie S; Liu M; Chen Z; Liu X; Wang L; Li D; Zhou Y Int J Oncol; 2014 Jul; 45(1):197-208. PubMed ID: 24805774 [TBL] [Abstract][Full Text] [Related]
26. miRNA expression in breast cancer varies with lymph node metastasis and other clinicopathologic features. Wang B; Li J; Sun M; Sun L; Zhang X IUBMB Life; 2014 May; 66(5):371-7. PubMed ID: 24846313 [TBL] [Abstract][Full Text] [Related]
27. Next generation sequencing profiling identifies miR-574-3p and miR-660-5p as potential novel prognostic markers for breast cancer. Krishnan P; Ghosh S; Wang B; Li D; Narasimhan A; Berendt R; Graham K; Mackey JR; Kovalchuk O; Damaraju S BMC Genomics; 2015 Sep; 16():735. PubMed ID: 26416693 [TBL] [Abstract][Full Text] [Related]
28. Lymphovascular invasion: a comprehensive appraisal in colon and rectal adenocarcinoma. Hogan J; Chang KH; Duff G; Samaha G; Kelly N; Burton M; Burton E; Coffey JC Dis Colon Rectum; 2015 Jun; 58(6):547-55. PubMed ID: 25944426 [TBL] [Abstract][Full Text] [Related]
29. Distribution characteristics of immune infiltration and lymphovascular invasion in patients with breast cancer skin recurrence. Zhou D; Li M; Wu W; Wu Y; Nong Q; Wang S; Hong R Cancer Immunol Immunother; 2024 Sep; 73(11):223. PubMed ID: 39235656 [TBL] [Abstract][Full Text] [Related]
30. The role of lymph node metastasis in the systemic dissemination of breast cancer. Nathanson SD; Kwon D; Kapke A; Alford SH; Chitale D Ann Surg Oncol; 2009 Dec; 16(12):3396-405. PubMed ID: 19657697 [TBL] [Abstract][Full Text] [Related]
31. Bcl-2 expression correlates with lymphovascular invasion and long-term prognosis in breast cancer. Neri A; Marrelli D; Roviello F; DeMarco G; Mariani F; DeStefano A; Megha T; Caruso S; Corso G; Cioppa T; Pinto E Breast Cancer Res Treat; 2006 Sep; 99(1):77-83. PubMed ID: 16541314 [TBL] [Abstract][Full Text] [Related]
32. Molecular Complexity of Lymphovascular Invasion: The Role of Cell Migration in Breast Cancer as a Prototype. Kariri YA; Aleskandarany MA; Joseph C; Kurozumi S; Mohammed OJ; Toss MS; Green AR; Rakha EA Pathobiology; 2020; 87(4):218-231. PubMed ID: 32645698 [TBL] [Abstract][Full Text] [Related]
33. BCL-6 oncoprotein in breast cancer: loss of expression in disease progression. Pinto AE; André S; Silva G; Vieira S; Santos AC; Dias S; Soares J Pathobiology; 2009; 76(5):235-42. PubMed ID: 19816083 [TBL] [Abstract][Full Text] [Related]
34. A clinical study to assess the pathological involvement of occult supraclavicular lymphnode metastasis in case of locally advanced operable breast carcinoma. Virani SJ; Patni S; Shah R Indian J Cancer; 2015; 52(3):282-5. PubMed ID: 26905111 [TBL] [Abstract][Full Text] [Related]
35. Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically. Saito K; Kawakami S; Fujii Y; Sakura M; Masuda H; Kihara K J Urol; 2007 Dec; 178(6):2291-6; discussion 2296. PubMed ID: 17936818 [TBL] [Abstract][Full Text] [Related]
36. A 15-gene signature for prediction of colon cancer recurrence and prognosis based on SVM. Xu G; Zhang M; Zhu H; Xu J Gene; 2017 Mar; 604():33-40. PubMed ID: 27998790 [TBL] [Abstract][Full Text] [Related]
37. Bioinformatics analysis of aggressive behavior of breast cancer via an integrated gene regulatory network. Yang X; Jia M; Li Z; Lu S; Qi X; Zhao B; Wang X; Rong Y; Shi J; Zhang Z; Xu W; Gao Y; Zhang S; Yu G J Cancer Res Ther; 2014; 10(4):1013-8. PubMed ID: 25579546 [TBL] [Abstract][Full Text] [Related]
38. Invasive Pleomorphic Lobular Histology Is an Adverse Prognostic Factor on Survival in Patients with Breast Cancer. Sahin S; Karatas F; Erdem GU; Hacioglu B; Altundag K Am Surg; 2017 Apr; 83(4):359-364. PubMed ID: 28424130 [TBL] [Abstract][Full Text] [Related]
39. Enhanced prediction of breast cancer prognosis by evaluating expression of p53 and prostate-specific antigen in combination. Yu H; Levesque MA; Clark GM; Diamandis EP Br J Cancer; 1999 Oct; 81(3):490-5. PubMed ID: 10507775 [TBL] [Abstract][Full Text] [Related]
40. Expression profiling of circulating tumor cells in metastatic breast cancer. Lang JE; Scott JH; Wolf DM; Novak P; Punj V; Magbanua MJ; Zhu W; Mineyev N; Haqq CM; Crothers JR; Esserman LJ; Tripathy D; van 't Veer L; Park JW Breast Cancer Res Treat; 2015 Jan; 149(1):121-31. PubMed ID: 25432738 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]